Is Spatialomics the Next Frontier of Synthetic Biology?

News, trends, and stories from the synthetic biology industry

Hi ,

This week, we bring you a look at the hottest new tool visualizing gene expression, Synthetic Biology Clubhouse breaking news, and the latest Biopharma Conference speakers:

Join us TODAY at 8 am PST for the Synthetic Biology Breaking News conversation on Clubhouse. Speakers include:
Stephanie Michelsen, CEO of Jellatech, who will be talking about their $2 million Pre-seed Round. The funding will enable them to further develop their cell-based, animal-free collagen and gelatin with applications in industries such as food & beverage, skincare & cosmetics, and medical & pharmaceutical.
Arturo Elizondo, Cristina Genovese, and Madelyn Rose Scarborough of Clara Foods, who announced an R&D partnership with ZX Ventures, the global investment and innovation group of AB InBev, to focus on unlocking scaled production for more sustainable, animal-free protein ingredients.

SynBioBeta In-Depth

Visualizing the Future: Spacialomics Transforms Study of Gene Expression
Spatialomics is considered by many to be the next frontier in understanding gene expression. By combining tissue imaging and single-cell transcriptomic analysis, spatialomics tools can create visual “maps'' of where and when genes are being expressed in individual cells. Could this new technology reveal root causes of diseases and help establish novel drug targets?

John Cumbers for Forbes

Printable DNA “Ink” Just Took A Big Step Forward
What if we could make DNA into an ink and put it inside a printer? This is the type of technology that Molecular Assemblies, which just closed a $24 million Series A financing, is working on. The goal is to make DNA ink that can be used for genomics printers to create nucleic acid-based vaccines and other types of therapeutics.

Biopharma Conference

For the first time ever, SynBioBeta is hosting a special event to answer all your burning biopharma questions. Check out the schedule here. What’s the current state of CRISPR-based medicine? What new investors are entering the biopharma space? What’s next for mRNA vaccines? Join us on May 26, 2021. Be sure to get your tickets now, prices increase April 22 at midnight PDT!

Science News

Adidas has revealed the first shoe made using Mylo: a new mushroom-based material innovation that looks and feels like leather – soft, supple, but a more renewable alternative. The new concept was made possible through a partnership with Bolt Threads.

A new method of breaking and fixing proteins could speed the development of sophisticated computer-like circuits in cells that will pave the way to new biotechnology and medical advances.
A team of scientists from the U.S., China, and Spain reported they have created the first embryos that were part human and part monkey and kept them alive for up to 20 days in laboratory dishes.

Funding news

Atlast Food Co., the mycelium food company growing plant-based meats, announced a $40 million Series A round to develop and supply whole cut plant-based meat. Their bacon that sizzles and tastes like the real thing but is made from a type of fungus has attracted financing from investors including a fund led by actor Robert Downey Jr.